Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed Aug 10, 2023 · 10-Q · 41 days after period end · 0001640334-23-001504
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2019 |
|---|---|---|---|---|
| Net Income | -$1.60M | -$2.45M | -$2.25M | -$424.79K |
| EPS Diluted | — | — | — | -$0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 10, 2023 · 41 d after period end
